ArticleJournal of applied clinical medical physics2026
Beam commissioning of a new compact scanned proton therapy system with four different dose calculation algorithms.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fluoroscopy-Guided Motion Management in Particle Therapy: Evolution, Challenges, and AI-Enabled Opportunities.Tomography (Ann Arbor, Mich.) · 2026Review
- Beam commissioning of a new compact scanned proton therapy system with four different dose calculation algorithms.Journal of applied clinical medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Central Japan International Medical Center (Gifu prefecture, Japan) as the 20th Proton Therapy Institution in Japan, has newly installed a compact scanned proton therapy system, ProBeam 360°™. We installed two commercial treatment planning systems (TPSs): Eclipse and RayStation. No commissioning results have been reported between Varian's newest compact proton therapy system and the two TPSs. PURPOSE: We identified the optimal dose calculation algorithm for clinical use by evaluating the dose agreements between four dose calculation algorithms provided by two TPSs and the measured values using our new machine.
methodsThe two TPSs each had a pencil beam algorithm (PBA) and Monte Carlo (MC) dose engines (four in total). Validation plans were created for 26 box targets (with and without a 50-mm range shifter) in a homogeneous phantom optimized using Eclipse. We created three realistic clinical plans consisting of 42 beams in mock patients with prostate, head and neck, and C-shaped targets. We validated 12 heterogeneous plans for the lung and bone regions using all three optimizations and four dose algorithms with the TPSs. Measurements were performed on the lateral profiles at the isocenter plane. The calculated doses for each algorithm were compared with the measured doses.
resultsEach dose algorithm achieved an average gamma score of at least 95.6 ± 5.0% or higher (RayStation PBA) at 3%/3 mm in the box plans. For the patient and heterogeneous plans, the average gamma score exceeded 95% for only two MC algorithms. RayStation MC showed the highest dose calculation accuracy in both homogeneous and heterogeneous regions.
conclusionsAll calculated doses of the box plans were in good agreement with the measurements, except for the RayStation PBA. For clinical use, RayStation MC is the preferred option for both homogeneous and heterogeneous cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.